Pharma R&D company scrutinizes software assets

UK-based FAST Ltd. finds in recent research that 60 percent of companies are under-licensed and 40 percent are over-licensed with their software. It cites Eisai, which manages the functions of marketing and sales, finance, medical information, market research and business operations for the pharmaceutical R&D operations of Eisai Europe and Eisai U.K., as one company that has benefited from implementing a software asset management program. Announcement